HLA-G and neoplasm: Tumor and serum HLA-G expression levels have been reported to be an independent marker of poor prognosis in several tumors, including NSCLC, ovarian, breast, colorectal, esophageal, gastric, hepatocellular and endometrial cancers [52,54,55,56,57].